| Value | ₹5.31 Cr |
|---|
BSE filing, NSE: ACC. Summary written from the filing by ALFA Finder's alert engine.
ACC Ltd: key numbers
- Share price
- ₹1,185.30
- Market cap
- ₹22,258 Cr
- Revenue (annual)
- ₹25,962 Cr
- Net profit (annual)
- ₹2,137 Cr
- P/E (TTM)
- 25.2×Sector 32.7×
- Promoter holding
- 56.69%+0.00% QoQ
- FII holding
- 5.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ACC Ltd
All →ACC Earnings Call Transcript: Key Takeaways
Ambuja Cements (filed by ACC) Q2 FY27: consol revenue ₹9,197 Cr, EBITDA ₹1,271 Cr (~14%), PAT ₹236 Cr; volumes flattish, capex stepped up.
ACC Investor Presentation: Key Takeaways
Ambuja consolidated Q2FY27: revenue ₹9,197 Cr flat YoY, EBITDA ₹1,271 Cr (-28%), margin 13.8%. Geopolitical cost hit ₹376 Cr. Debt-free.
ACC Annual General Meeting
ACC Limited has issued a postal ballot notice seeking member approval to appoint Mr. Vivek Paul as a Non-Executive Nominee Director representing LIC. E-voting runs from 30 Oct to 28 Nov 2026.
- Execution
- 30 Oct 2026 to 28 Nov 2026 (e-voting period)
ACC Results Update
ACC filed its Q2 FY27 media release highlighting improved trade mix and capacity additions. It commissioned 3.4 MTPA cement capacity and advanced the Ambuja merger to NCLT.
- cement manufacturing capacity
- 3.4 MTPA
ACC Q2 FY27 Results: Net Profit ₹93 Cr, Down 91.7% YoY
ACC Ltd reported revenue from operations of ₹5,666 Cr (-5.1% YoY) and net profit of ₹93 Cr (-91.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹93 Cr · -91.7% YoY
ACC Share Pledge
Deutsche Bank disclosed under SAST Reg 29(2) a new encumbrance over 106.46 million ACC shares (56.69%) tied to a refinancing facility. No shares were bought or sold, and the acquirer is a non-promoter.
Other merger & restructuring announcements
All →Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr